These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19219590)

  • 1. Validation of diagnostic tests for infectious diseases.
    Methods Mol Biol; 2009; 516():291-334. PubMed ID: 19219590
    [No Abstract]   [Full Text] [Related]  

  • 2. More advanced statistical methods for quality assurance, test validation, and interpretation.
    Methods Mol Biol; 2009; 516():467-516. PubMed ID: 19219594
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of diagnostic tests for infectious diseases: general principles.
    Banoo S; Bell D; Bossuyt P; Herring A; Mabey D; Poole F; Smith PG; Sriram N; Wongsrichanalai C; Linke R; O'Brien R; Perkins M; Cunningham J; Matsoso P; Nathanson CM; Olliaro P; Peeling RW; Ramsay A;
    Nat Rev Microbiol; 2006 Dec; 4(12 Suppl):S20-32. PubMed ID: 17366684
    [No Abstract]   [Full Text] [Related]  

  • 4. [International and regional standardization of immunoenzyme tests: methods, concerns and limitations].
    Desquesnes M
    Rev Sci Tech; 1997 Dec; 16(3):809-23. PubMed ID: 9567307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are enzyme-linked immunosorbent assay and immunoblot assay independent in immunodiagnosis of infectious diseases?
    Katti MK
    Clin Infect Dis; 2001 Apr; 32(7):1114. PubMed ID: 11264047
    [No Abstract]   [Full Text] [Related]  

  • 6. A guide for diagnostic evaluations.
    Peeling RW; Smith PG; Bossuyt PM
    Nat Rev Microbiol; 2006 Dec; 4(12 Suppl):S2-6. PubMed ID: 17110921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian meta-analysis of diagnostic tests allowing for imperfect reference standards.
    Menten J; Boelaert M; Lesaffre E
    Stat Med; 2013 Dec; 32(30):5398-413. PubMed ID: 24003003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of meta-analyses of diagnostic tests in infectious diseases.
    Cruciani M; Mengoli C
    Infect Dis Clin North Am; 2009 Jun; 23(2):225-67, Table of Contents. PubMed ID: 19393907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Applying an ultramicroanalytical system to the diagnosis of infectious diseases].
    Rivas Arjona MI; Laferté Serrano J; Alberti Amador E; Domínguez DR; González Muñoz G
    Rev Cubana Med Trop; 1992; 44(3):226-7. PubMed ID: 9768223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part II. Quality control: comparison of two charting methods to monitor assay performance.
    Goris N; De Clercq K
    Rev Sci Tech; 2005 Dec; 24(3):1005-16. PubMed ID: 16642771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnostic test technology: sensitivity and specificity, an OIE validation perspective.
    Schmitt B
    Biologicals; 2005 Dec; 33(4):211-3. PubMed ID: 16289686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A guide for diagnostic evaluations.
    Peeling RW; Smith PG; Bossuyt PM
    Nat Rev Microbiol; 2006 Sep; 4(9 Suppl):S2-6. PubMed ID: 17003769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an indirect enzyme-linked immunosorbent assay for the detection of antibody against Brucella abortus in cattle sera using an automated ELISA workstation.
    Paweska JT; Potts AD; Harris HJ; Smith SJ; Viljoen GJ; Dungu B; Brett OL; Bubb M; Prozesky L
    Onderstepoort J Vet Res; 2002 Mar; 69(1):61-77. PubMed ID: 12092779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test.
    Gengsheng Qin ; Hotilovac L
    Stat Methods Med Res; 2008 Apr; 17(2):207-21. PubMed ID: 18426855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part I. Quality assurance: development of secondary and working standards.
    Goris N; De Clercq K
    Rev Sci Tech; 2005 Dec; 24(3):995-1004. PubMed ID: 16642770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A toxicologist's guide to studying diagnostic tests.
    Bailey B; Amre DK
    Clin Toxicol (Phila); 2005; 43(3):171-9. PubMed ID: 15902791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis.
    Wright PF; Nilsson E; Van Rooij EM; Lelenta M; Jeggo MH
    Rev Sci Tech; 1993 Jun; 12(2):435-50. PubMed ID: 8400384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of serological assays for diagnosis of infectious diseases.
    Jacobson RH
    Rev Sci Tech; 1998 Aug; 17(2):469-526. PubMed ID: 9713892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on 'The partial area under the summary ROC curve'.
    Nadarajah S
    Stat Med; 2008 Jun; 27(14):2731-4; author reply 2734-5. PubMed ID: 17910010
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of point-of-care testing on the diagnosis of infectious diseases.
    Weiner RG; Tyler JK
    MLO Med Lab Obs; 2003 Aug; 35(8):36-7. PubMed ID: 12942660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.